Logo
N

NeuroSense Therapeutics

27 employees

NeuroSense Therapeutics is a clinical-stage drug development company, advancing a groundbreaking treatment for ALS.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
MND
CNS
ALS
Novel treatment
Biopharmaceuticals
Parkinson's Disease
Lou Gehrig's Disease
Neuroscience
Drug Development
Neurodegenerative Diseases
Alzheimer's disease

Date founded

2017

Funding rounds raised

Total raised

$529K

from 1 investors over 1 rounds

N

NeuroSense Therapeutics raised $529K on February 1, 2020

Investors: PipelBiz

FAQ